DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases

Information source: Healthsystem Plus
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cardiovascular Diseases; High Blood Pressure

Phase: N/A

Status: Recruiting

Sponsored by: Healthsystem Plus

Official(s) and/or principal investigator(s):
Uchenna N Onyeachom, Principal Investigator, Affiliation: Healthsystem Plus
Ngozi A Njepuome, Principal Investigator, Affiliation: Abuja Heart Study
Chimele Abengowe, Study Chair, Affiliation: National Hospital, Abuja

Overall contact:
Uchenna N Onyeachom, Email: uonyeachom@hvori.org

Summary

This is a multi-site prospective epidemiological investigation of cardiovascular disease (CVD) among Abuja residents from the rural and metropolitan area.

Clinical Details

Official title: Abuja Heart Study (AHS) is a Multi-site Prospective Epidemiological Investigation of Cardiovascular Disease (CVD) .

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: determine the roles of sociocultural factors, such as poverty,gender, literacy, stress in the development of CVD and associated risk factors

Secondary outcome: familial or hereditary factors

Detailed description: Sub-Saharan Africa continues to fight the battle of infectious diseases such as HIV/AIDS, Tuberculosis and Malaria. But given all the international efforts geared to curing and containing these diseases, and with progress made in various countries, Sub-Saharan Africa is now heading into another type of epidemic, cardiovascular disease (CVD). Predicted statistics have shown that cardiovascular diseases will become the leading cause of death in developing countries within the next 10 to 15 years, however relatively few population-based studies have examined CVD in Africa . Although control of communicable ,childhood ,and maternal diseases has benefited from an international efforts on clinical care, policy and implementation,such large scale effort are lacking for CVD and have left both policymakers and individuals with decisions on health issues without adequate information. Prior to the commencement of the study,series of community meetings and focus groups discussions will be held to identify ways to enhance participation. An extensive examination will include a series of questionnaires dealing with lifestyle habits, medical history, social and cultural factors, physical assessments which include height, weight,central blood pressure assessment of arterial stiffness and autonomic function and laboratory measurements for cholesterol, other lipids, glucose ,c-reactive protein among others.

Eligibility

Minimum age: 18 Years. Maximum age: 64 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Some history of cardiovascular disease,PLWHA

- Patients have to agree to participate by signing a consent

- 18 years and older

Exclusion Criteria:

- Stroke

Locations and Contacts

Uchenna N Onyeachom, Email: uonyeachom@hvori.org

Nigerian Defense Medical Center, Abuja, Nigeria; Recruiting

Gwagwalada Specialist Hospital, Federal Capital Territory, Nigeria; Recruiting

National Hospital Abuja, Abuja, Federal Capital Territory, Nigeria; Recruiting

State House Medical Center, Abuja, Federal Capital Territory, Nigeria; Recruiting

Bwari General Hospital, Bwari, Federal Capital Territory, Nigeria; Recruiting

Additional Information

Starting date: November 2009
Last updated: September 25, 2013

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017